about
Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revisedInflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseContribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.Is apolipoprotein E4 an important risk factor for vascular dementia?New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essayProgression of white matter lesions and hemorrhages in cerebral amyloid angiopathyCerebral microinfarcts associated with severe cerebral beta-amyloid angiopathyResorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.Compendium of cerebrovascular diseases.Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit.Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathyCritical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention.Cerebral microbleeds are associated with the progression of ischemic vascular lesions.Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease.Cerebral amyloid angiopathy in East and West.Cerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models.Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.Kidney disease in primary anti-phospholipid antibody syndrome.Identification of neurovascular changes associated with cerebral amyloid angiopathy from subject-specific hemodynamic response functions.Small vessel disease and subcortical vascular dementia.Association of Cerebral Microbleeds With Cognitive Decline and Dementia.Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy.High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice.Is Vascular Amyloidosis Intertwined with Arterial Aging, Hypertension and Atherosclerosis?Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia.Treatment of Vascular Cognitive Impairment.Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease.Lobar brain hemorrhages and white matter changes: Clinical, radiological and laboratorial profiles.Cerebral amyloid angiopathy causing non-haemorrhagic mass effect.Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
P2860
Q24796292-93C8979A-813D-46A6-A301-0C69417461F1Q27023953-7F475892-6824-418A-82D4-311C7F3004F8Q30623665-C01F7F28-1F57-41E3-8EF4-7BED73B2A65DQ30655480-A4E1ABB0-BB5F-466A-9715-6932012A8C0EQ34028845-94427068-F9E5-4D36-8E58-5471ECFC5234Q34163155-4ADC5278-F323-4F94-9E59-E7AEB3AF6EFDQ34770690-FA66CDFA-E6F1-4131-83AC-017C8B528F19Q35081397-E4AB552F-A0EC-4B8C-B96F-860F69A4591AQ35674780-E3751772-E207-4CF7-9DC7-E319BE75C842Q36448521-98F3EC0D-FA28-467D-980C-E6580CD8761AQ36645246-FDC994CD-E2A6-42F0-9F10-7933DA61DCADQ37186592-1C0D4845-162C-49D3-B383-D8384280C387Q37233478-172B9888-A473-4C8A-867C-9AA85009C90CQ37438267-374B817F-007D-46D0-8AD5-8FC2F17AF9A7Q37624552-8E974ABB-868C-4D92-9DB8-7551ACC6E50BQ37732549-60C9690C-BDC0-4B19-A021-E8FB7AA767C4Q37790450-12DA15DE-4DF2-4665-835E-F177DD3E3406Q38114940-860791A9-9E9D-4EED-B2F9-3EF271268E80Q38781187-6D3EA3AE-3B2B-4DBB-A6AC-FA1E9ACDCE10Q38934375-87191D46-23CD-4B36-81D7-8F739937895BQ38987236-564FD842-9D8A-411D-8D1D-D47516C43E7AQ40028069-DB3C8D29-1119-4463-B058-7A330E5EFE58Q40714238-062AE143-8909-4876-BB17-ED87680BCD03Q40998916-FA886183-10EF-4574-A6AA-78376C043500Q42123847-4D61EB90-B520-4A2E-B17C-506ACD59669FQ43209580-10632AE7-537A-4DC1-9B3E-1E04C5BC9B99Q47308471-AE7E2C52-8625-4F44-9122-BC7155117187Q48118846-D658B233-DA59-49EB-97F2-6135B7D9828BQ48336132-745BD556-0854-40D2-AB67-45981DB35311Q48543604-6ACBB85D-2776-48F9-B94D-0D927979E4EFQ48986234-5A35C338-30DF-4BA1-A317-7A48F13D5995Q52148897-F66AFDC7-D186-4189-8820-934DDE7882A8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cerebral amyloid angiopathy and vessel dysfunction.
@ast
Cerebral amyloid angiopathy and vessel dysfunction.
@en
Cerebral amyloid angiopathy and vessel dysfunction.
@nl
type
label
Cerebral amyloid angiopathy and vessel dysfunction.
@ast
Cerebral amyloid angiopathy and vessel dysfunction.
@en
Cerebral amyloid angiopathy and vessel dysfunction.
@nl
prefLabel
Cerebral amyloid angiopathy and vessel dysfunction.
@ast
Cerebral amyloid angiopathy and vessel dysfunction.
@en
Cerebral amyloid angiopathy and vessel dysfunction.
@nl
P356
P1476
Cerebral amyloid angiopathy and vessel dysfunction.
@en
P2093
Steven M Greenberg
P356
10.1159/000049149
P478
13 Suppl 2
P577
2002-01-01T00:00:00Z